HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PPBT
Purple Biotech Ltd.
There isn't enough reported data to score PPBT yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PPBT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Unavailable | |
| Unavailable |
PPBT's profitability is currently stable. There isn't enough data to rate its revenue, cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PPBT PE Valuation
PPBT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PPBT Forward outlook
There aren't enough analyst estimates for PPBT to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
PPBT has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus PPBT down 100%.
PPBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.03 | -100% |
| Q4 2024 | $49.90 | +$68.12 |
| Q4 2023 | -$18.22 | +$5.80 |
| Q3 2023 | -$20.98 | +$2.28 |
| Q2 2023 | -$21.70 | -$0.20 |
| Q1 2023 | -$20.74 | +$0.96 |
| Q4 2022 | -$24.02 | -$2.98 |
| Q4 2021 | -$21.04 | -104% |
PPBT has returned to profit: it earned $0.03 per share over the past year, after losing money the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
PPBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2019 | $1M | 0% |
PPBT's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2020 | -1261% | -824 points |
| Q2 2019 | -356% | N/A |
| Q2 2018 | -437% | N/A |
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
PPBT has the stronger cash trend. Its trailing FCF is down 3.5% versus its history, compared with HIMS at down 84%.
PPBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$5M | -$768K |
| Q3 2023 | -$3.7M | -$29K |
| Q2 2023 | -$5.2M | -$1.5M |
| Q1 2023 | -$6.1M | -$650K |
| Q4 2022 | -$4.2M | -$461K |
| Q3 2022 | -$3.6M | -$680K |
| Q2 2022 | -$3.7M | +$1.5M |
| Q1 2022 | -$5.4M | -$1.9M |
PPBT has burned cash in almost every quarter: −$20M over the past year, against −$18M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has 234M diluted shares, down 6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PPBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -87% | -1.1M shares |
| 1 year | -83% | -828K shares |
| 3 years | -81% | -705K shares |
PPBT has the edge over HIMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PPBT Net Leverage
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PPBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 26.0 | Neutral |
PPBT's weekly RSI is 37 (neutral) and its Stochastic is 26 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PPBT PE vs Healthcare Sector
| Metric | PPBT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PPBT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PPBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.33 | 17% above |
| 20 week MA | $1.46 | 6.8% above |
| 50 week MA | $3.47 | 55% below |
| 100 week MA | $12.9 | 88% below |
| 200 week MA | $105.0 | 99% below |
PPBT has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over PPBT on returns for 2026, with the stronger performance.
PPBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,519.8 | $826.0 | -46% |
| 2021 | $826.0 | $842.0 | +1.9% |
| 2022 | $842.0 | $316.0 | -62% |
| 2023 | $316.0 | $156.0 | -51% |
| 2024 | $156.0 | $43.6 | -72% |
| 2025 | $43.6 | $7.06 | -84% |
| 2026 YTD | $7.06 | $1.56 | -78% |
PPBT has finished four years in a row lower, and it's down 78% so far in 2026.